LEARNING OBJECTIVES Upon completion of the activity, participants should be able to:

• Evaluate clinical trial data on available and emerging treatments for IPF and potential application to practice

ACTIVITY FACULTY Imre Noth, MD Professor of Medicine Director, Interstitial Lung Disease Program The University of Chicago Medicine Chicago, Illinois